InvestorsHub Logo
Followers 32
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: ATLnsider post# 608063

Sunday, 07/09/2023 8:07:52 PM

Sunday, July 09, 2023 8:07:52 PM

Post# of 703710
To be taken seriously, I’d start by putting some timelines including info on market access for each of the major markets (US, UK, Canada and EU). I’d also remove worldwide approvals! I told this to you about 1 or 2 years ago and how even EU was going to be extremely challenging for this team in terms of reimbursements. It’s just not a good utilization of their resources over the next few years.

You have been saying this for 2-3 years now, but let’s get UK and US approvals for GBM indication in 2024. Hopefully, we will be at a $1 with UK approval in 2024 and stay there. Then we will dream about FDA around end of 2024 or 2025. We will reach 1.6B OS by then. Forget about EU approvals/reimbursements and tissue agnostic. This management will not be around if and when they start planning for those milestones.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News